Xenon Pharmaceuticals to Present at the Jefferies 2020 Virtual Healthcare Conference

Rhea-AI Summary

Xenon Pharmaceuticals announced that Dr. Simon Pimstone, the CEO, will present a company overview at the Jefferies Virtual Healthcare Conference on June 3, 2020, at 2:30 pm ET. Investors can access the presentation through a webcast on the company's website, with a replay available afterward. Xenon is focused on developing innovative therapeutics for neurological disorders, particularly epilepsy, through its robust clinical-stage pipeline.

BURNABY, British Columbia, June 01, 2020 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, announced today that Dr. Simon Pimstone, Xenon’s Chief Executive Officer, will present a company overview at the Jefferies Virtual Healthcare Conference on Wednesday, June 3, 2020 at 2:30 pm Eastern time.

A webcast will be available on the investors section of the Xenon website at http://investor.xenon-pharma.com and will be available for replay following the event.

About Xenon Pharmaceuticals Inc.

We are a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit www.xenon-pharma.com.

“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.

Investor/Media Contact:
Jodi Regts
Xenon Pharmaceuticals Inc.
Phone: 604.484.3353
Email: investors@xenon-pharma.com

FAQ

What is the date and time of Xenon Pharmaceuticals' presentation at the Jefferies Virtual Healthcare Conference?

Xenon Pharmaceuticals will present on June 3, 2020, at 2:30 pm ET.

Where can I watch the Xenon Pharmaceuticals conference presentation?

The presentation can be viewed via a webcast on the investor section of Xenon Pharmaceuticals' website.

What is the main focus of Xenon Pharmaceuticals' product pipeline?

Xenon Pharmaceuticals focuses on developing therapeutics for neurological disorders, especially epilepsy.

Who is presenting at the Jefferies Virtual Healthcare Conference for Xenon Pharmaceuticals?

Dr. Simon Pimstone, the CEO of Xenon Pharmaceuticals, will be presenting.